Scinai Immunotherapeutics (SCNI) Asset Utilization Ratio (2026)
Scinai Immunotherapeutics' (SCNI) Asset Utilization Ratio was 0.10 for Q2 2026, down 1.4% from the prior quarter.
Powered by 
Analysis
Scinai Immunotherapeutics (SCNI) Asset Utilization Ratio (2026) Analysis & Trends
For FY2025, Asset Utilization Ratio at Scinai Immunotherapeutics was 0.19, up 347.7% from FY2024.
- By year, Asset Utilization Ratio came in at 0.04 in FY2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 0.62 |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 0.49 |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 0.47 |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 0.52 |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 0.46 |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 0.51 |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 0.40 |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 0.58 |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 0.31 |
| 10 | Scinai Immunotherapeutics | 147,049.82 | -8.12 Mn | -1.25 Mn | 0.10 |
API Access
Scinai Immunotherapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=SCNI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "SCNI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=SCNI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();